Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

10 February, 2026 | Tuesday

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate

The BENEGENE-2 study met its primary endpoint of non-inferiority and superiority in the annualized bleeding rate (ABR) of total bleeds post-fidanacogene el...

January 02, 2023 | Monday | News

Biocytogen Launches RenNano™ Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery

While humans and mice generate antibodies that require heavy and light chain pairing to be functional, camels and sharks generate heavy-chain-only antibodi...

January 02, 2023 | Monday | News

36
37
38
39
40
41
42
43
44
45

Partner Content

BioPharma BreakThrough's

Affidea Acquires Majority Stake in LabPoint to Build Integrated Precision Diagnostics Platform in Switzerland
16 January, 2026
Enginzyme and AGC Present Scalable Manufacturing Process for Key mRNA Ingredient m¹ΨTP
13 January, 2026
Incyte Announces FDA Breakthrough Therapy Designation for INCA033989 for Essential Thrombocythemia with Type 1 CALR Mutation
08 December, 2025
AstraZeneca Showcases Broad Advances in Blood Cancer and Rare Disease Care With 65 Presentations at ASH 2025
05 December, 2025
MUVON Therapeutics Reports Positive Topline Results From Phase 2 SUISSE-MPC2 Trial of MPC-Based Therapy in Female Stress Urinary Incontinence
04 December, 2025
VNA-318 Demonstrates Strong Target Engagement and Safety in First-in-Human Trial
03 December, 2025

Editor Picks

China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne
30 January, 2026
Elevar Submits NDA for Lirafugratinib as Second-Line FGFR2-Driven Cholangiocarcinoma Therapy
30 January, 2026
Imviva Biotech’s CTD402 Granted FDA Orphan Drug Designation for Relapsed/Refractory T-ALL/LBL
29 January, 2026

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2026 Biopharma Boardroom. All Rights Reserved.